Gilvocarcin V, a Photodynamic DNA Damaging Agent Of Unusual Potency

Gilvocarcin V (GV) is a planar, aromatic DNA-intercalating C-glycoside isolated as a natural product antibiotic. In the presence of UVA or visible radiation, it becomes a DNA damaging agent at low doses in both bacterial and mammalian cells. In mice treated without regard to light exposure, GV exhibited antitumor activity at high doses, with little accompanying toxicity. Wavelength-dependence studies showed that lambda prophage induction profiles were similar to (part of) the absorption spectrum of GV, with a peak near 400 nm. However, significant induction at a higher wavelength (546 nm), was observed at relatively high (e.g. 1 μg/m1) concentrations of GV. The DNA damaging activity of GV was dependent on both the concentration of antibiotic and the fluence of radiation in a reciprocal manner. Mutagenesis and DNA binding experiments suggest a preference for interaction with AT-rich regions of DNA, but multiple modes of interaction seem likely. The presence of different C-glycosides on the gilvocarcin V chromophore may alter the pharmacological properties of the molecule, but photoactivation appears to be independent of these groups. The therapeutic possibilities of gilvocarcins remain largely unexplored; the demonstrated potency of these compounds when activated, the reciprocity effect, possibility of structural variation, and apparent lack of toxicity in mammalian systems are properties which could be exploited in therapeutic development.

[1]  F. Strelitz,et al.  CHRYSOMYCIN: A NEW ANTIBIOTIC SUBSTANCE FOR BACTERIAL VIRUSES , 1955, Journal of bacteriology.

[2]  P. Roller,et al.  Detection of gilvocarcin antitumor complex by a biochemical induction assay (BIA). , 1982, The Journal of antibiotics.

[3]  R. C. Pandey,et al.  Defucogilvocarcin V, a new antibiotic from Streptomyces arenae 2064: isolation, characterization, partial synthesis and biological activity. , 1985, The Journal of antibiotics.

[4]  M. Greenstein,et al.  Studies on the mechanism of actin of gilvocarcin V and chrysomycin A. , 1982, The Journal of antibiotics.

[5]  R. White,et al.  Light-dependent activity of the antitumor antibiotics ravidomycin and desacetylravidomycin , 1986, Antimicrobial Agents and Chemotherapy.

[6]  Y. Tse‐Dinh,et al.  Light-induced modifications of DNA by gilvocarcin V and its aglycone. , 1987, Biochemical and biophysical research communications.

[7]  R. White,et al.  The chemistry of the antibiotics chrysomycin A and B. Antitumor activity of chrysomycin A. , 1982, The Journal of antibiotics.

[8]  J. Clardy,et al.  Antitumor agents from Streptomyces anandii: gilvocarcins V, M and E. , 1981, The Journal of antibiotics.

[9]  R. White,et al.  Biochemical prophage induction assay: a rapid test for antitumor agents that interact with DNA. , 1983, Cancer research.

[10]  R. Saucier,et al.  Ravidomycin (AY-25,545), a new antitumor antibiotic. , 1983, The Journal of antibiotics.

[11]  H. Nakano,et al.  GILVOCARCINS, NEW ANTITUMOR ANTIBIOTICS , 1981 .

[12]  R. Elespuru,et al.  Activation of antitumor agent gilvocarcins by visible light. , 1984, Science.

[13]  Y. Kameda,et al.  Toromycin, a new antibiotic produced by Streptomyces collinus subsp. albescens subsp. nov. , 1980 .

[14]  S. Rakhit,et al.  Chemical modification of ravidomycin and evaluation of biological activities of its derivatives. , 1983, The Journal of antibiotics.

[15]  M. Uramoto,et al.  Studies on binding of toromycin, an antitumor antibiotic, to DNA. , 1986, Biochemical and biophysical research communications.

[16]  R. Elespuru,et al.  WAVELENGTH DEPENDENCE FOR THE INDUCTION OF BACTERIOPHAGE LAMBDA BY ANTITUMOR AGENT GILVOCARCIN V , 1986, Photochemistry and photobiology.